Skip to main content
Top
Gepubliceerd in:

13-07-2021

Development of a conceptual model of patient-reported outcomes in light chain amyloidosis: a qualitative study

Auteurs: Anita D’Souza, Judith Myers, Rachel Cusatis, Angela Dispenzieri, Muriel Finkel, Julie Panepinto, Kathryn E. Flynn

Gepubliceerd in: Quality of Life Research | Uitgave 4/2022

Log in om toegang te krijgen
share
DELEN

Deel dit onderdeel of sectie (kopieer de link)

  • Optie A:
    Klik op de rechtermuisknop op de link en selecteer de optie “linkadres kopiëren”
  • Optie B:
    Deel de link per e-mail

Abstract

Background

Light chain (AL) amyloidosis is a plasma cell neoplasm associated with high early mortality and severe morbidity that can cause severe disability. We explored the impact of AL amyloidosis on symptoms and well-being from the perspectives of patients and health care providers who regularly care for AL patients. We intended to develop a conceptual understanding of patient-reported outcomes in AL amyloidosis to identify the context of use and concept of interest for a clinical outcome assessments tool in this disease.

Method

Twenty patients and ten professionals were interviewed. Patient interviews captured the spectrum of amyloidosis experience including time from diagnosis, type of organ involvement, and presence and type of treatment received. Interviews with professionals included physicians, advanced practice providers, registered nurse, and a patient advocate; these interviews covered similar topics.

Results

The impact of AL amyloidosis on patients’ life was multidimensional, with highly subjective perceptions of normality and meaning. Four major themes from patients and experts included diagnosis of AL amyloidosis, living with AL amyloidosis, symptom burden, and social roles. Barriers to patient-reported outcomes data collection in patients were additionally explored from experts. The themes provide a comprehensive understanding of the important experiences of symptom burden and its impact on daily life from AL amyloidosis patients’ and from the perspectives of professionals who care for patients with AL amyloidosis.

Conclusion

These findings further the conceptual understanding and identification of a preliminary model of concept of interest for development of a clinical outcome assessments tool for AL amyloidosis.
Bijlagen
Alleen toegankelijk voor geautoriseerde gebruikers
Literatuur
2.
go back to reference Merlini, G. (2017). AL amyloidosis: from molecular mechanisms to targeted therapies. Hematology/The Education Program of the American Society of Hematology. American Society of Hematology. Education Program, 2017(1), 1–12. Merlini, G. (2017). AL amyloidosis: from molecular mechanisms to targeted therapies. Hematology/The Education Program of the American Society of Hematology. American Society of Hematology. Education Program, 2017(1), 1–12.
3.
go back to reference Lousada, I., Comenzo, R. L., Landau, H., Guthrie, S., & Merlini, G. (2015). Light chain amyloidosis: Patient experience survey from the Amyloidosis Research Consortium. Advances in Therapy, 32(10), 920–928.CrossRef Lousada, I., Comenzo, R. L., Landau, H., Guthrie, S., & Merlini, G. (2015). Light chain amyloidosis: Patient experience survey from the Amyloidosis Research Consortium. Advances in Therapy, 32(10), 920–928.CrossRef
6.
go back to reference Lin, H. M., Seldin, D., Hui, A. M., Berg, D., Dietrich, C. N., & Flood, E. (2015). The patient’s perspective on the symptom and everyday life impact of AL amyloidosis. Amyloid : The International Journal of Experimental and Clinical Investigation : The Official Journal of the International Society of Amyloidosis, 22(4), 244–251. https://doi.org/10.3109/13506129.2015.1102131CrossRef Lin, H. M., Seldin, D., Hui, A. M., Berg, D., Dietrich, C. N., & Flood, E. (2015). The patient’s perspective on the symptom and everyday life impact of AL amyloidosis. Amyloid : The International Journal of Experimental and Clinical Investigation : The Official Journal of the International Society of Amyloidosis, 22(4), 244–251. https://​doi.​org/​10.​3109/​13506129.​2015.​1102131CrossRef
7.
go back to reference Rizio, A. A., White, M. K., McCausland, K. L., Quock, T. P., Guthrie, S. D., Yokota, M., & Bayliss, M. S. (2018). Treatment tolerability in patients with immunoglobulin light-chain amyloidosis. American Health & Drug Benefits, 11(8), 430. Rizio, A. A., White, M. K., McCausland, K. L., Quock, T. P., Guthrie, S. D., Yokota, M., & Bayliss, M. S. (2018). Treatment tolerability in patients with immunoglobulin light-chain amyloidosis. American Health & Drug Benefits, 11(8), 430.
9.
go back to reference Aronson, J. (1995). A pragmatic view of thematic analysis. The Qualitative Report, 2(1), 1–3. Aronson, J. (1995). A pragmatic view of thematic analysis. The Qualitative Report, 2(1), 1–3.
10.
go back to reference Cella, D., Yount, S., Rothrock, N., Gershon, R., Cook, K., Reeve, B., …PROMIS Cooperative Group. (2007) The patient-reported outcome measurement information system (PROMIS): Progress of an NIH Roadmap Cooperative Agreement during its first two years. Medical Care 45 S3 Cella, D., Yount, S., Rothrock, N., Gershon, R., Cook, K., Reeve, B., …PROMIS Cooperative Group. (2007) The patient-reported outcome measurement information system (PROMIS): Progress of an NIH Roadmap Cooperative Agreement during its first two years. Medical Care 45 S3
11.
go back to reference DeWalt, D. A., Rothrock, N., Yount, S., & Stone, A. A. (2007). Evaluation of item candidates: The PROMIS qualitative item review. Medical Care, 45(5 Suppl 1), S12.CrossRef DeWalt, D. A., Rothrock, N., Yount, S., & Stone, A. A. (2007). Evaluation of item candidates: The PROMIS qualitative item review. Medical Care, 45(5 Suppl 1), S12.CrossRef
12.
go back to reference Riley, W. T., Pilkonis, P., & Cella, D. (2011). Application of the National Institutes of Health patient-reported outcomes measurement information system (PROMIS®) to mental health research. The Journal of Mental Health Policy and Economics, 14(4), 201.PubMedPubMedCentral Riley, W. T., Pilkonis, P., & Cella, D. (2011). Application of the National Institutes of Health patient-reported outcomes measurement information system (PROMIS®) to mental health research. The Journal of Mental Health Policy and Economics, 14(4), 201.PubMedPubMedCentral
14.
16.
go back to reference Wright, N. L., Flynn, K. E., Brazauskas, R., Hari, P., & D’Souza, A. (2018). Patient-reported distress is prevalent in systemic light chain (AL) amyloidosis but not determined by severity of disease. Amyloid : The International Journal of Experimental and Clinical investigation : The Official Journal of the International Society of Amyloidosis, 25(2), 129–134. https://doi.org/10.1080/13506129.2018.1486298CrossRef Wright, N. L., Flynn, K. E., Brazauskas, R., Hari, P., & D’Souza, A. (2018). Patient-reported distress is prevalent in systemic light chain (AL) amyloidosis but not determined by severity of disease. Amyloid : The International Journal of Experimental and Clinical investigation : The Official Journal of the International Society of Amyloidosis, 25(2), 129–134. https://​doi.​org/​10.​1080/​13506129.​2018.​1486298CrossRef
19.
go back to reference D’Souza, A., Magnus, B. E., Myers, J., Dispenzieri, A., & Flynn, K. E. (2020). The use of PROMIS patient-reported outcomes (PROs) to inform light chain (AL) amyloid disease severity at diagnosis. Amyloid : The International Journal of Experimental and Clinical Investigation : The Official Journal of the International Society of Amyloidosis. https://doi.org/10.1080/13506129.2020.1713743CrossRef D’Souza, A., Magnus, B. E., Myers, J., Dispenzieri, A., & Flynn, K. E. (2020). The use of PROMIS patient-reported outcomes (PROs) to inform light chain (AL) amyloid disease severity at diagnosis. Amyloid : The International Journal of Experimental and Clinical Investigation : The Official Journal of the International Society of Amyloidosis. https://​doi.​org/​10.​1080/​13506129.​2020.​1713743CrossRef
Metagegevens
Titel
Development of a conceptual model of patient-reported outcomes in light chain amyloidosis: a qualitative study
Auteurs
Anita D’Souza
Judith Myers
Rachel Cusatis
Angela Dispenzieri
Muriel Finkel
Julie Panepinto
Kathryn E. Flynn
Publicatiedatum
13-07-2021
Uitgeverij
Springer International Publishing
Gepubliceerd in
Quality of Life Research / Uitgave 4/2022
Print ISSN: 0962-9343
Elektronisch ISSN: 1573-2649
DOI
https://doi.org/10.1007/s11136-021-02943-w

Andere artikelen Uitgave 4/2022

Quality of Life Research 4/2022 Naar de uitgave